Patient and multidisciplinary team perspectives on watch and wait in rectal cancer

被引:3
作者
Mohan, Helen [1 ,2 ,3 ,8 ]
Rabie, Mohammed [2 ]
Walsh, Ciaran [4 ]
Harji, Deena [2 ]
Sutton, Paul [5 ]
Geh, Ian [4 ]
Jackson, Ian [6 ]
Helbren, Emma [7 ]
Evans, Martyn [4 ]
Jenkins, John T. [1 ,4 ]
机构
[1] ACPGBI Adv Malignancy Subcomm, London, England
[2] Dukes Club, London, England
[3] Univ Melbourne, Dept Surg, Melbourne, Australia
[4] ACPGBI Multidisciplinary Clin Comm, London, England
[5] Early Years Consultant Network, London, England
[6] ACPGBI Patient Liaison Grp, London, England
[7] British Soc Gastrointestinal Abdominal Radiol BSGA, London, England
[8] Peter MacCallum Canc Ctr, ACPGBI Adv Malignancy Subcomm, 305 Grattan St, Melbourne, Vic, Australia
关键词
complete response; organ preservation; rectal cancer; watch and wait; CLINICAL COMPLETE RESPONSE; X-RAY BRACHYTHERAPY; LONG-TERM OUTCOMES; NEOADJUVANT CHEMORADIOTHERAPY; PREOPERATIVE CHEMORADIOTHERAPY; NONOPERATIVE TREATMENT; INTERNATIONAL WATCH; ORGAN PRESERVATION; OPEN-LABEL; CHEMORADIATION;
D O I
10.1111/codi.16592
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This article adopts a multidisciplinary approach, including surgery, oncology, radiology and patient perspectives, to discuss the key points of debate surrounding a watch and wait approach. In an era of shared decision-making, discussion of watch and wait as an option in the context of complete clinical response is appropriate, although it is not the gold standard treatment. Key challenges are the difficulty in assessing for a complete clinical response, prediction of recurrence and access to timely diagnostics for surveillance. Salvage surgery has good results if regrowth is detected early but does have imperfect outcomes, with only a 90% salvage rate. Good communication with patients about the risks and alternatives is essential. Patients undergoing watch and wait should ideally be enrolled in prospective registries or clinical trials.
引用
收藏
页码:1489 / 1497
页数:9
相关论文
共 59 条
  • [1] [Anonymous], 2015, MONTGOMERY LANARKSHI
  • [2] Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years
    Bahadoer, Renu R.
    Peeters, Koen C. M. J.
    Beets, Geerard L.
    Figueiredo, Nuno L.
    Bastiaannet, Esther
    Vahrmeijer, Alexander
    Temmink, Sofieke J. D.
    Kranenbarg, W. M. Elma Meershoek-Klein
    Roodvoets, Annet G. H.
    Habr-Gama, Angelita
    Perez, Rodrigo O.
    van de Velde, Cornelis J. H.
    Hilling, Denise E.
    [J]. BRITISH JOURNAL OF SURGERY, 2022, 109 (01) : 114 - 120
  • [3] Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
    Bahadoer, Renu R.
    Dijkstra, Esmee A.
    van Etten, Boudewijn
    Marijnen, Corrie A. M.
    Putter, Hein
    Kranenbarg, Elma Meershoek-Klein
    Roodvoets, Annet G. H.
    Nagtegaal, Iris D.
    Beets-Tan, Regina G. H.
    Blomqvist, Lennart K.
    Fokstuen, Tone
    ten Tije, Albert J.
    Capdevila, Jaume
    Hendriks, Mathijs P.
    Edhemovic, Ibrahim
    Cervantes, Andres
    Nilsson, Per J.
    Glimelius, Bengt
    van de Velde, Cornelis J. H.
    Hospers, Geke A. P.
    [J]. LANCET ONCOLOGY, 2021, 22 (01) : 29 - 42
  • [4] A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial
    Battersby, Nick J.
    Dattani, Mit
    Rao, Sheela
    Cunningham, David
    Tait, Diana
    Adams, Richard
    Moran, Brendan J.
    Khakoo, Shelize
    Tekkis, Paris
    Rasheed, Shahnawaz
    Mirnezami, Alex
    Quirke, Philip
    West, Nicholas P.
    Nagtegaal, Iris
    Chong, Irene
    Sadanandam, Anguraj
    Valeri, Nicola
    Thomas, Karen
    Frost, Michelle
    Brown, Gina
    [J]. TRIALS, 2017, 18
  • [5] Watch-and-Wait Compared to Operation for Patients with Complete Response to Neoadjuvant Therapy for Rectal Cancer
    Beard, Bryce W.
    Rettig, Robert L.
    Ryoo, Joan J.
    Parker, Rex A.
    McLemore, Elisabeth C.
    Attaluri, Vikram
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (06) : 681 - 692
  • [6] Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting
    Beets-Tan, Regina G. H.
    Lambregts, Doenja M. J.
    Maas, Monique
    Bipat, Shandra
    Barbaro, Brunella
    Curvo-Semedo, Luis
    Fenlon, Helen M.
    Gollub, Marc J.
    Gourtsoyianni, Sofia
    Halligan, Steve
    Hoeffel, Christine
    Kim, Seung Ho
    Laghi, Andrea
    Maier, Andrea
    Rafaelsen, Soren R.
    Stoker, Jaap
    Taylor, Stuart A.
    Torkzad, Michael R.
    Blomqvist, Lennart
    [J]. EUROPEAN RADIOLOGY, 2018, 28 (04) : 1465 - 1475
  • [7] Rectal Cancer, Version 2.2022
    Benson, Al B., III
    Venook, Alan P.
    Al-Hawary, Mahmoud M.
    Azad, Nilofer
    Chen, Yi-Jen
    Ciombor, Kristen K.
    Cohen, Stacey
    Cooper, Harry S.
    Deming, Dustin
    Garrido-Laguna, Ignacio
    Grem, Jean L.
    Gunn, Andrew
    Hecht, J. Randolph
    Hoffe, Sarah
    Hubbard, Joleen
    Hunt, Steven
    Jeck, William
    Johung, Kimberly L.
    Kirilcuk, Natalie
    Krishnamurthi, Smitha
    Maratt, Jennifer K.
    Messersmith, Wells A.
    Meyerhardt, Jeffrey
    Miller, Eric D.
    Mulcahy, Mary F.
    Nurkin, Steven
    Overman, Michael J.
    Parikh, Aparna
    Patel, Hitendra
    Pedersen, Katrina
    Saltz, Leonard
    Schneider, Charles
    Shibata, David
    Skibber, John M.
    Sofocleous, Constantinos T.
    Stotsky-Himelfarb, Eden
    Tavakkoli, Anna
    Willett, Christopher G.
    Gregory, Kristina
    Gurski, Lisa
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (10): : 1139 - 1167
  • [8] Deep Learning and Radiomics predict complete response after neo-adjuvant chemoradiation for locally advanced rectal cancer
    Bibault, Jean-Emmanuel
    Giraud, Philippe
    Durdux, Catherine
    Taieb, Julien
    Berger, Anne
    Coriat, Romain
    Chaussade, Stanislas
    Dousset, Bertrand
    Nordlinger, Bernard
    Burgun, Anita
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [9] Feasibility study of a Response Surveillance Program in locally advanced mid and low rectal cancer to increase organ preservation
    Boubaddi, Mehdi
    Fleming, Christina
    Vendrely, Veronique
    Frulio, Nora
    Salut, Cecile
    Rullier, Eric
    Denost, Quentin
    [J]. EJSO, 2023, 49 (01): : 237 - 243
  • [10] Urinary and sexual dysfunction in women after resection with and without preoperative radiotherapy for rectal cancer: a population-based cross-sectional study
    Bregendahl, S.
    Emmertsen, K. J.
    Lindegaard, J. C.
    Laurberg, S.
    [J]. COLORECTAL DISEASE, 2015, 17 (01) : 26 - 37